The HER Foundation is bringing the voices of HG women to a research conference at the University of Pittsburgh in early October. The Biology and Control of Nausea and Vomiting 2013 is targeted to both basic researchers and clinical investigators working in the field of nausea and vomiting. The conference will be useful for clinicians needing up-to-date information about treatments for nausea and vomiting, such as in patients suffering from hyperemesis gravidarum (HG).
“The biology of nausea and vomiting has been under-researched and underfunded. Conference sponsorship from the HER Foundation is critical for efforts to raise awareness,” said Charles Horn, Ph.D., Asssociate Professor at the University of Pittsburgh and conference co-organizer.
The HER Foundaiton is excited that Marlena Fejzo, Ph.D., a HER Foundation Board member and lead researcher on HG at UCLA, will be speaking at the event. Dr. Fejzo will discuss herresearch the past few years, which has been funded by the HER Foundation, and what she hopes the future for HG women looks like when it comes to research.
“Having the HER Foundation represented at the conference will foster communications and programmatic links between clinical problems and researchers focused on understanding the biological foundations of nausea and vomiting. These interactions could lead to research efforts and novel therapies that will ultimately benefit women experiencing hyperemesis gravidarum,” Dr. Horn said.
The HER Foundation has been dedicated to helping HG women for more than10 years and attending this conference is a huge step for HG women around the globe, knowing that not only will researchers be discussing HG, but listening to the voices and pleas of HG women thanks to the continuous efforts of the HER Foundation.
